Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;27(35):3668-3685.
doi: 10.2174/1381612827666210315145254.

Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases

Affiliations
Review

Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases

Khushdeep Bandesh et al. Curr Pharm Des. 2021.

Abstract

Long non-coding RNAs (lncRNAs) are functionally versatile molecules that regulate gene expression at all levels of biological organization. RNA modulation, at the moment, has emerged as a powerful therapeutic technique to treat human diseases. Lately, lncRNAs have been acknowledged as key players in human metabolism and, indeed, implicated in the etiology of many common diseases other than cancers, where they can perhaps serve as reliable markers to determine disease status or assess outcomes of an intervention. Here, in this review, we cite examples of such lncRNAs, discuss their mechanistic role in human diseases and their genetic association, quote potential biomarkers found in human blood, summarize the methods for therapeutic targeting lncRNAs and examine the progress of lncRNA based drugs in clinical trials. Thus, we propose that lncRNAs serve as both a biomarker and an effective therapeutic target with promising clinical utility to manage human metabolic diseases.

Keywords: Epigenetics; RNA therapeutics; cardiovascular disease; human metabolism.; lncRNAs; neurological disease; obesity; type 2 diabetes.

PubMed Disclaimer

Publication types

LinkOut - more resources